1. Introduction {#sec1}
===============

The infectious diseases are widely managed by the antimicrobial agents but increase in resistance of microorganisms towards antimicrobial agents in the past few years has become a serious health care problem, and this has led to the necessity of designing of some novel, potent, and safe antimicrobial agents against resistant microbial strains. The compounds having Mannich bases are found to have broad spectrum activity against all strains resistant to other drugs. Mannich bases have gained importance due to their application in antibacterial activity \[[@B1]--[@B3]\].

Mannich bases are the end products of Mannich reaction with basic moiety of beta amino ketone \[[@B4], [@B5]\]. Mannich bases are formed by the condensation of a compound with active hydrogen(s) with an amine (primary or secondary) and formaldehyde (any aldehyde) \[[@B6]\].

Computational studies are the starting point which can be used to predict the experimental data of entirely known molecule or to explore reaction mechanisms and so forth. There are several areas of computational studies and one of them is identification of correlations between chemical structures and properties and is known as QSAR. Quantitative structural activity relationship uses molecular parameters to quantify a pharmacological or chemical property for a set of molecules \[[@B7], [@B8]\].

In the present work, novel series of seven benzamide substituted Mannich bases are prepared and further screened for the antibacterial activity against Gram negative bacteria (*Escherichia coli, Pseudomonas aeruginosa*) and Gram positive bacteria (*Enterococcus faecalis, Staphylococcus aureus*). Computational studies including QSAR and molecular structural similarity studies were also performed to establish a relationship between biological activities in terms of minimum inhibitory concentration with various physicochemical parameters using multilinear regression.

2. Material and Method {#sec2}
======================

2.1. Chemistry {#sec2.1}
--------------

TLC plates of 3 × 15 cm coated with silica gel *G* were used for reaction monitoring and for determination of retardation factor. Spots of TLC were located by iodine chamber. Melting points of newly synthesized benzamide substituted Mannich bases were determined on digital melting point apparatus (Flora; Perfit India) and were found uncorrected ([Table 1](#tab1){ref-type="table"}). The structures of the synthesized derivatives were confirmed by spectral data. The *λ* ~max~ was calculated by using double beam UV-Visible 1800 Shimadzu spectrophotometer. The IR spectra were recorded on FTIR-Shimadzu spectrometer using Nujol method. ^1^H NMR and ^13^C NMR spectra were recorded on BRUKER AVANCE II NMR spectrometer using DMSO as solvent and TMS as internal standard; chemical shift values were expressed in *δ* ppm. For mass spectra, solutions were made in HPLC grade methanol and spectra were obtained with Vg-11-250 J70S spectrophotometer at 70 eV using electron ionization (EI source). Chem3D Ultra (version 10) was employed for structural similarity studies \[[@B9]\]. QSAR studies were performed by multilinear regression using Analyze it version 3.0 software.

### 2.1.1. Synthesis {#sec2.1.1}

A series of benzamide substituted Mannich bases were synthesized as per [Figure 1](#fig1){ref-type="fig"}.

*General Procedure for the Synthesis of Benzamide*. To 1 mL of benzoyl chloride, 2 mL of ammonium hydroxide (30%) was added. This mixture was allowed to stand for 2 minutes and then 4 mL water was added to it. The crude product was recrystallized with ethanol \[[@B10]\].

*N-(Morpholin-4-ylmethyl)benzamide*(**1**)*\[[@B11], [@B12]\]*. Benzamide (0.001 M) was dissolved in ethanol. To this morpholine (0.001 M) and (0.015 M) formaldehyde were added. The reaction mixture was refluxed for 1 hour and the reaction was monitored by TLC. Light brown colored crystals were obtained after evaporating the solvent. Mp 65--67°C; IR (Nujol): 3428.13, 3050.47, 2828.85, 1655.23, 1543.20, 1539.42, 1432.65, 1309.87, 1277.90, 1058.66, 1012.79, 817.81 cm^−1^; ^1^H NMR (DMSO-d~6~ 400 MHz): 8.0 (br, s, 1H, --NH), 7.95 (m, 2H, Ar--H), 7.51 (m, 3H, Ar--H), 4.27 (s, 2H, --CH~2~), 3.67 (s, 4H, --H of morpholine), 2.37 (s, 4H, --H of morpholine); ^13^C NMR: 71.5 (C-2,6), 53.9 (C-3,5), 64 (C-7), 167.4 (C-9), 132.9 (C-11), 127.6 (C-12,16), 131.9 (C-13,14,15); MS: *m/z* 220.12, 221.10 (M+1), 222.13 (M+2); Anal. Cal. for C~12~H~16~N~2~O~2~: C: 65.43, H: 7.32, N: 12.72, O: 14.53. Found: C: 65.23, H: 7.39, N: 12.12, O: 14.33.

*N-(Piperazine-1-ylmethyl)benzamide* (**2**)  *\[[@B13]\]*. Benzamide (0.001 M) was dissolved in ethanol. To this piperazine (0.001 M) and (0.015 M) formaldehyde were added. The reaction mixture was refluxed for 7-8 hours and the reaction was monitored by TLC. Dark brown colored crystals were obtained after evaporating the solvent. Mp 68--70°C; IR (Nujol): 3414.15, 3053.45, 2839.88, 1648.24, 1567.23, 1534.44, 1433.66, 1306.83, 1012.73, 818.82 cm^−1^; ^1^H NMR (DMSO-d~6~ 400 MHz): 8.4 (br, s, 1H, --NH), 7.98 (m, 2H, Ar--H), 7.52 (m, 3H, Ar--H), 4.26 (s, 2H, --CH~2~), 2.65 (s, 4H, --H of piperazine), 2.48 (s, 4H, --H of piperazine), 2.0 (br, s, 1H, --NH); ^13^C NMR: 50.8 (C-2,6), 55.1 (C-3,5), 64.1 (C-7), 168.2 (C-9), 133.2 (C-11), 127.9 (C-12,16), 130.9 (C-13,14,15); MS: *m/z* 219.14, 220.14 (M+1), 221.17 (M+2); Anal. Cal. for C~12~H~17~N~3~O: C: 65.73, H: 7.81, N: 19.16, O: 7.30. Found: C: 65.79, H: 7.61, N: 19.26, O: 7.32.

*N-\[(4-Bromo-phenylamino)-methyl\]-benzamide* (**3**). Benzamide (0.001 M) was dissolved in ethanol. To this 4-bromoaniline (0.001 M) and (0.015 M) formaldehyde were added. The reaction mixture was refluxed for 9-10 hours and the reaction was monitored by TLC. Light orange colored crystals were obtained after evaporating the solvent. Mp 66--69°C; IR (Nujol): 3439.23, 3052.48, 2834.52, 1645.25, 1538.30, 1502.61, 1460.15, 1094.64, 1015.57, 852.57 cm^−1^; ^1^H NMR (DMSO-d~6~ 400 MHz): 8.2 (br, s, 1H, --NH), 7.95 (m, 2H, Ar--H), 7.56 (m, 3H, Ar--H), 7.21 (d, 2H, Ar--H), 6.32 (d, 2H, Ar--H), 4.97 (t, 2H, --CH~2~), 4.0 (br, s, 1H, --NH); ^13^C NMR: 38.6 (C-1), 30.8 (C-2,6), 29.6 (C-3,5), 47.9 (C-4), 57.8 (C-9), 168.2 (C-11), 133.5 (C-13), 127.3 (C-14,18), 129.7 (C-15,16,17); MS: *m/z* 304.02, 306.02 (M+1), 305.01 (M+2); Anal. Cal. for C~14~H~13~BrN~2~O: C: 55.10, H: 4.29, Br: 26.18, N: 9.18, O: 5.24. Found: C: 55.18, H: 4.19, Br: 26.28, N: 9.08, O: 5.44.

*N-Phenyl-aminomethyl-benzamide* (**4**). Benzamide (0.001 M) was dissolved in ethanol. To this aniline (0.001 M) and (0.015 M) formaldehyde were added. The reaction mixture was refluxed for 9-10 hours and the reaction was monitored by TLC. Light brown colored crystals were obtained after evaporating the solvent. Mp 98--101°C; IR (Nujol): 3442.12, 3054.41, 2836.59, 1652.10, 1539.26, 1504.54, 1440.28, 1013.64, 822.68 cm^−1^; ^1^H NMR (DMSO-d~6~ 400 MHz): 8.1 (br, s, 1H, --NH), 7.98 (m, 2H, Ar--H), 7.52 (m, 3H, Ar--H), 6.58 (m, 2H, Ar--H), 7.04 (m, 3H, Ar--H), 4.96 (s, 2H, --CH~2~), 4.2 (br, s, 1H, --NH); ^13^C NMR: 48.6 (C-1), 33.4 (C-2,6), 24.3 (C-3,4,5), 57.8 (C-8), 168.4 (C-10), 133.0 (C-12), 127.6 (C-13,17), 131.2 (C-14,15,16); MS: *m/z* 226.11, 227.13 (M+1), 228.12 (M+2); Anal. Cal. for C~14~H~14~N~2~O: C: 74.31, H: 6.24, N: 12.38, O: 7.07. Found: C: 74.38, H: 6.04, N: 12.39, O: 7.13.

*N-\[(4-Sulfamoyl-phenylamino)-methyl\]-benzamide* (**5**). Benzamide (0.001 M) was dissolved in ethanol. To this sulfanilamide (0.001 M) and (0.015 M) formaldehyde were added. The reaction mixture was refluxed for 10--12 hours and the reaction was monitored by TLC. Colorless crystals were obtained after evaporating the solvent. Mp 69-70°C; IR (Nujol): 3310.16, 3054.41, 2854.69, 1636.52, 1541.19, 1534.44, 1440.82, 1320.22, 1135.55, 1080.18, 863.18 cm^−1^; 8.2 (br, s, 1H, --NH), 7.96 (m, 2H, Ar--H), 7.71 (d, 2H, Ar--H), 7.51 (m, 3H, Ar--H), 6.71 (d, 2H, Ar--H), 4.94 (t, 2H, --CH~2~), 4.0 (br, s,1H, --NH), 2.0 (br, s, 2H, --NH~2~); ^1^H NMR (DMSO-d~6~ 400 MHz): 8.1 (br, s, 1H, --NH), 7.98 (m, 2H, Ar--H), 7.52 (m, 3H, Ar--H), 6.58 (m, 2H, Ar--H), 7.04 (m, 3H, Ar--H), 4.96 (s, 2H, --CH~2~), 4.2 (br, s,  1H, --NH); ^13^C NMR: 58.4 (C-1), 15.7 (C-2,6), 29.5 (C-3,5), 48.6 (C-4), 57.4 (C-10), 167.9 (C-12), 132.9 (C-16), 127.6 (17,21), 130.4 (C-18,19,20); MS: *m/z* 305.09, 306.10 (M+1), 307.08 (M+2); Anal. Cal. for C~14~H~15~N~3~O~3~S: C: 55.07, H: 4.95, N: 13.76, O: 15.72, S: 10.50. Found: C: 55.13, H: 4.75, N: 13.26, O: 15.79, S: 10.42.

*N-\[(2-Nitro-phenylamino)-methyl\]-benzamide*  (**6**). Benzamide (0.001 M) was dissolved in ethanol. To this 2-nitroaniline (0.001 M) and (0.015 M) formaldehyde were added. The reaction mixture was refluxed for 10--12 hours and the reaction was monitored by TLC. Yellow colored crystals were obtained after evaporating the solvent. Mp 68--70°C; IR (Nujol): 3423.80, 3050.21, 2831.05, 1646.32, 1540.19, 1524.36, 1509.36, 1462.21, 1098.51, 1306.55, 859.32 cm^−1^; ^1^H NMR (DMSO-d~6~ 400 MHz): 8.4 (br, s, 1H, --NH), 7.97 (m, 1H, Ar--H), 7.95 (m, 2H, Ar--H), 7.54 (m, 3H, Ar--H), 7.43 (m, 1H, Ar--H), 6.84 (m, 1H, Ar--H), 6.69 (m, 1H, Ar--H), 4.99 (s, 2H, --CH~2~), 4.21 (br, s, 1H, --NH); ^13^CNMR: 46.9 (C-1), 28.8 (C-2), 21.3 (21.3), 22.5 (C-4), 22.9 (C-5), 85.3 (C-6), 129.4 (C-15,16,17); MS: *m/z* 271.10, 272.10 (M+1), 273.15 (M+2); Anal. Cal. for C~14~H~13~N~3~O~5~: C: 61.99, H: 4.83, N: 15.49, O: 17.69. Found: C: 61.91, H: 4.80, N: 15.55, O: 17.42.

*N-\[(2,4-Dinitro-phenylamino)-methyl\]-benzamide* (**7**). Benzamide (0.001 M) was dissolved in ethanol. To this 2,4-dinitroaniline (0.001 M) and (0.015 M) formaldehyde were added. The reaction mixture was refluxed for 10--12 hours and the reaction was monitored by TLC. Yellow colored crystals were obtained after evaporating the solvent. Mp 69--72°C; IR (Nujol): 3426.80, 3052.21, 2835.05, 1641.32, 1545.19, 1530.36, 1502.36, 1466.21, 1099.51, 1304.55, 862.32 cm^−1^; ^1^H NMR (DMSO-d~6~ 400 MHz): 8.90 (m, 1H, Ar--H), 8.36 (m, 1H, Ar--H), 8.2 (br, s, 1H, --NH), 7.95 (m, 2H, Ar--H), 7.5 (m, 3H, Ar--H), 6.95 (m, 1H, Ar--H), 4.94 (s, 2H, --CH~2~), 4.1 (br, s, 1H, --NH); ^13^C NMR; 45.9 (C-1), 24.2 (C-2), 21.9 (C-3), 76.7 (C-4), 23.5 (C-5), 80.7 (C-6), 56.7 (C-8), 167.9 (C-10), 133.2 (C-15), 127.9 (C-16,20), 130.2 (C-17,18,19); MS: *m/z* 316.09, 317.10 (M+1), 318.10 (M+2); Anal. Cal. for C~14~H~12~N~4~O~5~: C: 53.17, H: 3.82, N: 17.71, O: 25.29. Found: C: 53.23, H: 3.88, N: 17.72, O: 25.18.

3. Biological Evaluation {#sec3}
========================

3.1. Antibacterial Activity {#sec3.1}
---------------------------

The inhibition of the microbial growth may be utilized for demonstrating the therapeutic efficacy of the synthesized compounds. The Gram negative bacteria (*Escherichia coli, Pseudomonas aeruginosa*) and Gram positive bacteria  (*Enterococcus faecalis, Staphylococcus aureus*) were used for the activity.

The antibacterial activity was evaluated by tube dilution method which depends upon the inhibition of growth of a microbial culture in a uniform solution of antibiotic in a fluid medium that is favorable to its rapid growth in the absence of the antibiotic \[[@B14]\]. In this method minimum inhibitory concentration (MIC) of the test compounds was determined. The MIC is the lowest concentration of an antimicrobial agent that inhibits the growth of the test organism \[[@B15]\]. Test compounds and standard compounds (amoxicillin and cefixime) were dissolved in dimethyl sulfoxide to give a concentration of 100 *μ*g/mL. Double strength nutrient broth I.P. was used. Suspension of each microorganism was made by transferring the organism from culture to 10 mL of sterile normal saline solution.

*Determination of Minimum Inhibitory Concentration (MIC)*. One mL of sterilized media was poured into sterile test tubes. One mL of 100 *μ*g/mL test solution was transferred in one tube and serially diluted to give concentrations of 50, 25, 12.5, 6.25, 3.12, 1.56, and 0.78 *μ*g/mL. To all the tubes 0.1 mL of suspension of bacteria in saline was added and the tubes were incubated at 37°C for 24 h. The growth in the tube was observed visually for turbidity and inhibition was determined by the absence of growth. MIC was determined by the lowest concentration of sample that retarded the development of turbidity. The activity of the compounds compared with the standard drugs (amoxicillin and cefixime) is given in [Table 2](#tab2){ref-type="table"}. Graphical representation of minimum inhibitory concentration (MIC) of benzamide substituted Mannich bases against Gram positive and negative bacterial strains is given in Figures [2](#fig2){ref-type="fig"} and [3](#fig3){ref-type="fig"}, respectively.

4. Molecular Structural Similarity Studies {#sec4}
==========================================

Assessments of molecular structural similarity of synthesized benzamide substituted Mannich bases were compared to those of standard compounds by means of physicochemical similarity between the standard drugs and new analogues designed. The information was used for prediction of biological activity of important target compounds for novel drug discovery. The physicochemical parameters were calculated for the synthesized compounds using Chem3D Ultra (version 10) and compared with the values obtained for standard compounds (cefixime and tosufloxacin tosylate). Various set of parameters were used for calculations as given in [Table 3](#tab3){ref-type="table"}.

The distance *d* ~*i*~ of a particular target compound *i* can be presented as $$\begin{matrix}
{d_{i}^{2} = \frac{\sum_{j = 1}^{n}\left( {1 - X_{i,j}/X_{i,\text{standard}}} \right)^{2}}{n},} \\
\end{matrix}$$ where *X* ~*i*,*j*~ is the value of molecular parameters *i* for compound *j*.

*X* ~*i*,standard~ is the value of the same molecular parameter *i* for standard drug.

*n* is the total number of the considered molecular parameters.

The similarity of the compounds can be calculated as $$\begin{matrix}
{\%{\,\,}\text{age}{\,\,}\text{similarity} = \left( {1 - R} \right) \times 100,} \\
\end{matrix}$$ where *R* is quadratic mean also known as the root mean square and *R* can be calculated as $$\begin{matrix}
{R = \sqrt{d_{i}^{2}}.} \\
\end{matrix}$$ Assessment of structural similarities of synthesized compounds with standard drugs showed that all the derivatives have good % age similarity ([Table 4](#tab4){ref-type="table"}).

5. Quantitative Structure Activity Relationship (QSAR) {#sec5}
======================================================

The synthesized substituted Mannich bases were subjected to QSAR analysis by using multilinear regression. For this analysis, various physicochemical parameters were calculated and correlated with biological activity, that is, antibacterial activity to obtain QSAR models. The physicochemical parameters were computed using Chem3D (Version 10) Ultra after energy minimization to minimum root mean square (RMS) gradient of 0.100 kcal/mole Å by MOPAC software package. Out of all the physicochemical parameters ([Table 4](#tab4){ref-type="table"}), the following five parameters were selected for QSAR studies: log *P*, Connolly solvent accessible surface area (SAS), molar refractivity (MR), ovality, and molecular weight (MW). Biological activity data was converted to the logarithmic values. For antibacterial activity, biological activity was taken as −log(MIC/molecular weight of compound).

5.1. Statistical Analysis {#sec5.1}
-------------------------

The statistical significance of the models was assessed on the basis of various parameters such as *R* ^2^ (coefficient of correlation), *R* ~adj~ ^2^ (coefficient of determination), *Q* ^2^ (cross validates *R* ^2^), and *F* (Fischer statistics), considering all the parameters in the model significant only at 95% confidence level (*P* \< 0.05).

Basic structure of synthesized benzamide substituted Mannich bases is shown in [Scheme 1](#sch1){ref-type="fig"}.

*(I) QSAR Model for Antibacterial Activity against Escherichia coli:* $$\begin{matrix}
{\text{pMIC} = 0.06413\left( {\log\operatorname{}P} \right) - 0.009411\left( \text{SAS} \right)} \\
{- 0.003046\left( \text{MW} \right) + 8.615\left( \text{Ovality} \right){\,\,}} \\
{- 0.02413\left( \text{MR} \right) - 4.57,} \\
{N = 7,\quad\quad R^{2} = 0.921,\quad\quad{\,\,}R_{\text{adj}}^{2} = 0.529,} \\
{\text{Press} = 0.00000025,\quad\quad Q^{2} = 0.999,\quad\quad} \\
{F = 2.35,\quad\quad S = 0.188.} \\
\end{matrix}$$ Here and hereafter,  *R* ^2^: is coefficient of correlation, *R* ~adj~ ^2^: is coefficient of determination, *F*: is Fischer statistics, *N*: is number of test compounds, Press: is predictive error sum of squares, *Q* ^2^: is cross validated *R* ^2^, BA: is biological activity, and *S*: is standard error of estimation.

The observed and predicted antibacterial activity of synthesized benzamide substituted Mannich bases are summarized in [Table 5](#tab5){ref-type="table"} and plot of calculated and observed antibacterial activity is given in [Figure 4](#fig4){ref-type="fig"}.

*(II) QSAR Model for Antibacterial Activity against Staphylococcus aureus:* $$\begin{matrix}
{\text{pMIC} = 0.06698\left( {\log\operatorname{}P} \right) - 0.02004\left( \text{SAS} \right)} \\
{+ 0.003104\left( \text{MW} \right) + 5.643\left( \text{Ovality} \right)} \\
{- 0.04099\left( \text{MR} \right) + 3.876,} \\
{N = 7,\quad\quad R^{2} = 986,\quad\quad R_{\text{adj}}^{2} = 0.913,\quad\quad} \\
{\text{Press} = 0.00094,\quad\quad Q^{2}{\,\,} = {\,\,}0.999,\quad\quad{\,\,}} \\
{F{\,\,} = {\,\,}13.66,\quad\quad S{\,\,} = {\,\,}0.095.} \\
\end{matrix}$$ The observed and predicted antibacterial activity of synthesized benzamide substituted Mannich bases are summarized in [Table 6](#tab6){ref-type="table"} and plot of calculated and observed antibacterial activity is given in [Figure 4](#fig4){ref-type="fig"}.

*(III) QSAR Model for Antibacterial Activity against Pseudomonas aeruginosa:* $$\begin{matrix}
{\text{pMIC} = 0.08457\left( {\log\operatorname{}P} \right) - 0.008497\left( \text{SAS} \right)} \\
{- 0.006487\left( \text{MW} \right) + 7.007\left( \text{Ovality} \right)} \\
{- 0.03631\left( \text{MR} \right) - 1.385,} \\
{N = 7,\quad\quad R^{2}{\,\,} = {\,\,}0.997,\quad\quad{\,\,}R_{\text{adj}}^{2} = 0.982,} \\
{\text{Press} = 0.00009,\quad\quad Q^{2} = 0.998,\quad} \\
{F = 65.56,\quad\quad{\,\,}S = 0.034.} \\
\end{matrix}$$ The observed and predicted antibacterial activity of synthesized benzamide substituted Mannich bases are summarized in [Table 7](#tab7){ref-type="table"} and plot of calculated and observed antibacterial activity is given in [Figure 5](#fig5){ref-type="fig"}.

*(IV) QSAR Model for Antibacterial Activity against Enterococcus faecalis:* $$\begin{matrix}
{\text{pMIC} = 0.0383\left( {\log\operatorname{}P} \right) - 0.02271\left( \text{SAS} \right)} \\
{+ 0.002366\left( {\text{M}.\text{W}} \right) + 8.135\left( \text{Ovality} \right)} \\
{- 0.03458\left( \text{MR} \right) + 1.51,} \\
{N = 7,\quad\quad R^{2} = 0.963,\quad\quad R_{\text{adj}}^{2} = 0.779,\quad\quad} \\
{\text{Press} = 0.00000009,\quad\quad Q^{2} = 0.998,\quad\quad} \\
{F = 5.23,\quad\quad{\,\,}S = 0.139.} \\
\end{matrix}$$ The observed and predicted antibacterial activity of synthesized benzamide substituted Mannich bases are summarized in [Table 8](#tab8){ref-type="table"} and plot of calculated and observed antibacterial activity is given in [Figure 5](#fig5){ref-type="fig"}.

6. Result and Discussion {#sec6}
========================

6.1. Chemistry {#sec6.1}
--------------

The structures of synthesized derivatives were supported by means of chromatographic and spectroscopic methods. Both analytical and spectral data (IR and ^1^H NMR) of all the synthesized derivatives were in full agreement with the proposed structures. The structures of the synthesized derivatives were proven by the spectroscopic method. The structures assigned to (**1**--**7**) were supported by IR spectra showing absorption bands at 3,442--3,310 cm^−1^ due to N--H stretching. Carbonyl stretch was observed at 1,655--1,636 cm^−1^. Stretching vibrations due to C=C (aromatic) were observed at 1,539--1,502 cm^−1^, respectively. Bands at 1,509--1,502 cm^−1^ appeared due to asymmetric N=O stretch. Bands at 863-817 cm^−1^ indicated out-of-plane aromatic stretch. The proton NMR of these compounds revealed the presence of downfield singlet 8.0--8.9 ppm for --CONH. A 2 protons singlet at 4.27--4.99 ppm appeared due to protons of methylene group. All the other aliphatic and aromatic protons were observed within the expected regions. This part concluded the synthesis of benzamide substituted Mannich bases.

6.2. Biological Activity {#sec6.2}
------------------------

### 6.2.1. Antibacterial Activity {#sec6.2.1}

The minimum inhibitory concentrations of **5**(12.5, 6.25, 3.125, and 6.25), **6**(6.25, 6.25, 6.25, and 12.5), and **7**(3.125, 3.125, 3.125, and 6.25) were found to be good which is comparable with MIC of both standard drugs amoxicillin (1.56, 1.56, 3.125, and 3.125) and cefixime (6.25, 6.25 12.5, and 6.25). No inhibitory effect was observed for DMSO used as control. The MIC of **7** was found to be better than cefixime and MIC of **6** was found to be comparatively similar to cefixime. While studying MIC against bacterial strains **7**was found to be most active among all the synthesized benzamide substituted Mannich bases. From the above results it was concluded that compounds bearing substitutions such as sulphonamido **5**, *p-*nitro **6**, and dinitro group **7**have emerged out as potent antibacterial agents.

The compounds bearing nitro groups were found to have significant potential against all bacterial strains. This activity was attributed to lipophilic nature of these substituents which ultimately facilitate the transportation of target compounds across the biological membranes to produce desired effect. Both nitro and sulphonamide groups are an efficient --I, --R group, but the nature of the latter (low log*P* value) is more hydrophilic than the former (high log*P* value). Hence the contribution of sulphonamide group towards antibacterial activity is comparatively less than compounds bearing nitro groups.

### 6.2.2. Similarity Studies {#sec6.2.2}

Assessment of structural similarities of synthesized benzamide substituted Mannich bases with antibacterial drugs (cefixime and tosufloxacin tosylate) indicated that all the derivatives have shown good percentage of similarity ranging from 52.89% to 97.72% and compound **1** was found to have excellent percentage of similarity (\>90%) with all standard drugs. The structural similarity of all the compounds with standard drugs varying from one compound to another. This may be due to the large difference between the values of physicochemical parameters calculated for target compounds with values of parameters calculated for standard drugs. However good structural similarity of compounds does not always lead to good therapeutic activity as compound **1**has shown an excellent percentage of similarity (52.89--97.72%), but it was found to be less active as antibacterial agent.

6.3. Quantitative Structure Activity Relationship (QSAR) Analysis {#sec6.3}
-----------------------------------------------------------------

The results suggested that antibacterial activity was highly dependent on log*P*, SAS, MR, ovality, and MW. All the developed models have good coefficient of correlation (0.963--0.997), coefficient of determination (0.529--0.982), and cross validated *R* ^2^ (0.998--0.999) with Fischer statistics (2.35--65.56). The derived models could be used in designing of more potent inhibitors against bacterial infection. The five parameters correlated; statistically sound QSAR models for antibacterial activity against *Staphylococcus aureus*, *Enterococcus faecalis, Escherichia coli,* and *Pseudomonas aeruginosa* could be used for the prediction of biological activities of unknown and unavailable compounds of this class. In the present study, an attempt has been made to design some active antibacterial agents with lesser side effects. The QSAR results have shown the dependence of antibacterial activity of synthesized substituted benzamide Mannich base derivatives on their structural and physicochemical features. The results indicated that the bulkier aromatic substituents like sulphonamido group may increase lipophilicity and give better antibacterial activity. The presence of electron withdrawing group like --NO~2~ in the compound resulted in enhanced biological activity by improving lipophilicity. This lipophilicity could facilitate penetration or passage of these compounds across the biological membrane easily for beneficial therapeutic effect.

7. Conclusion {#sec7}
=============

In antibacterial activity, the compounds **5**, **6**, and **7**were observed as good antibacterial agents and compound **7**was found to be the most active against all the selected bacterial strains. The compound **1**was found to have excellent percentage of similarity (\>90%) with all standard drugs. The results suggested that antibacterial activity is highly dependent on physicochemical parameters such as log*P*, Connolly solvent accessible surface area (SAS), molar refractivity (MR), ovality, and molecular weight (MW). The derived model could be used in the future for designing of more potent inhibitors of bacterial infection.
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###### 

Physical data of synthesized benzamide substituted Mannich bases.

  Compound   Color                   Solubility            *λ* ~max~   *R* ~*f*~ value^\#^   \% age yield   Molecular weight
  ---------- ----------------------- --------------------- ----------- --------------------- -------------- ------------------
  1          Light brown crystals    DMSO, EtOH, CHCl~3~   226         0.45                  84             220.273
  2          Dark brown crystals     DMSO, EtOH, CHCl~3~   324         0.61                  78.2           219.288
  3          Light orange crystals   DMSO, EtOH, CHCl~3~   227         0.78                  76             305.176
  4          Light brown crystals    DMSO, EtOH, CHCl~3~   275         0.71                  70.8           226.279
  5          Colorless crystals      DMSO, EtOH, CHCl~3~   253         0.65                  91.6           302.378
  6          Yellow crystals         DMSO, EtOH, CHCl~3~   371         0.82                  75             271.277
  7          Yellow crystals         DMSO, EtOH, CHCl~3~   346         0.73                  80             316.275

  ^\#^Stationary phase: silica gel. Mobile phase for TLC: petroleum ether : ethyl acetate : methanol (6 : 3 : 1). Iodine vapors as visualizing agent.

###### 

Minimum inhibitory concentration (MIC) of the synthesized benzamide substituted Mannich bases against Gram positive and Gram negative bacteria.

  Compounds     Minimum inhibitory concentration (MIC) (*μ*g/mL)                   
  ------------- -------------------------------------------------- ------- ------- -------
  1             12.5                                               12.5    12.5    12.5
  2             12.5                                               12.5    6.25    12.5
  3             12.5                                               25      6.25    6.25
  4             25                                                 12.5    12.5    25
  5             12.5                                               6.25    3.125   6.25
  6             6.25                                               6.25    6.25    12.5
  7             3.125                                              3.125   3.125   6.25
  Control       ---                                                ---     ---     ---
  Amoxicillin   1.56                                               1.56    3.125   3.125
  Cefixime      6.25                                               6.25    12.5    6.25

###### 

Calculation of various molecular properties of the synthesized benzamide substituted Mannich bases.

  Compound   SAS^a^ (Å^2^)   MS^b^ (Å^2^)   CSEV^c^ (Å^3^)   Ovality   MR^d^ (cm^3^/mol)   MTI^e^   WI^f^   BI^g^     MW^h^     log *P*
  ---------- --------------- -------------- ---------------- --------- ------------------- -------- ------- --------- --------- ---------
  1          448.081         228.85         191.50           1.4243    61.4384             3711     496     89200     220.273   1.0523
  2          512.423         268.228        223.94           1.5040    42.9696             8354     1126    343784    305.36    1.484
  3          538.939         291.721        262.45           1.4715    30.8167             9773     1244    354337    302.378   4.943
  4          443.839         227.461        194.33           1.4019    63.1193             3795     496     89200     219.288   0.8303
  5          464.20          234.624        187.75           1.4796    51.6276             4798     614     124234    226.278   2.7389
  6          483.994         250.613        208.85           1.4721    48.2504             5338     727     164356    305.176   3.5678
  7          470.56          247.467        212.78           1.4357    35.1809             6884     925     256945    271.277   ---
  Std.1\*    580.224         331.272        320.88           1.4614    10.691              15459    2353    1046550   437.46    ---
  Std.2\*    570.267         318.963        282.94           1.5303    9.792               13519    2039    748946    404.350   2.419

  ^a^Connolly solvent accessible surface area. ^b^Connolly molecular surface area. ^c^Connolly solvent excluded volume. ^d^Molar refractivity.

^e^Molecular topological index. ^f^Wiener index. ^g^Balaban index. ^h^Molecular weight. Std.1\*---cefixime, Std.2\*---tosufloxacin tosylate.

###### 

Assessment of structural similarity of synthesized benzamide substituted Mannich bases with standard drugs.

  --------------------------------------------------
  Compound   Cefixime\      Tosufloxacin tosylate\
             (1 − *R*)100   (1 − *R*)100
  ---------- -------------- ------------------------
  1          72.7           97.72

  2          84             67.9

  3          90.34          52.89

  4          68.2           66.3

  5          95.2           69.5

  6          91             54

  7          74             96.7
  --------------------------------------------------

###### 

Observed and predicted antibacterial activity of synthesized benzamide substituted Mannich bases against *Escherichia coli*.

  Compound   Observed activity   Predicted activity   Residual
  ---------- ------------------- -------------------- ----------
  1          1.246051254         1.398072             −0.15202
  2          1.68893213          1.692905             −0.00397
  3          1.684670173         1.688051             −0.00338
  4          1.244104854         1.145049             0.099056
  5          1.85979231          1.810427             0.049366
  6          1.688673205         1.692826             −0.00415
  7          1.938562952         1.922897             0.015666

###### 

Observed and predicted antibacterial activity of synthesized benzamide substituted Mannich bases against *Staphylococcus aureus*.

  Compound   Observed activity   Predicted activity   Residual
  ---------- ------------------- -------------------- ------------
  1          1.246051254         1.170593             0.07545782
  2          1.387902134         1.38014              0.00776234
  3          1.38360177          1.386275             −0.0026351
  4          0.943074858         0.991585             −0.0485102
  5          1.257732318         1.286955             −0.0292232
  6          1.688673205         1.692675             −0.0040022
  7          1.93925838          1.947837             −0.0085788

###### 

Observed and predicted antibacterial activity of synthesized substituted benzamide Mannich bases against *Pseudomonas aeruginosa*.

  Compound   Observed activity   Predicted activity   Residual
  ---------- ------------------- -------------------- ----------
  1          1.246051            1.217519             0.028532
  2          1.387902            1.384015             0.003887
  3          1.68467             1.684545             0.000125
  4          0.943075            0.959732             −0.01666
  5          1.558762            1.568366             −0.0096
  6          1.387643            1.388065             −0.00042
  7          1.637533            1.639689             −0.00216

###### 

Observed and predicted antibacterial activity of synthesized benzamide substituted Mannich bases against *Enterococcus faecalis*.

  Compound   Observed activity   Predicted activity   Residual
  ---------- ------------------- -------------------- ----------
  1          1.246051            1.358788             −0.11274
  2          1.387902            1.401507             −0.0136
  3          1.08261             1.0811               0.00151
  4          1.244105            1.174548             0.069557
  5          1.558762            1.517701             0.041061
  6          1.688673            1.684798             0.003875
  7          1.939258            1.928613             0.010645
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